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Abstract. 
 
We report that the small GTPase, ADP-ribo-
sylation factor 6 (ARF6), is present only on the apical 
surface of polarized MDCK epithelial cells. Overex-
pression of a mutant of ARF6, ARF6–Q67L, which is 
predicted to be in the GTP-bound form, stimulates en-
docytosis exclusively at this surface. Surprisingly, over-
expression of the mutant ARF6–T27N, which is pre-
dicted to be in the GDP-bound form, also stimulated 
apical endocytosis, though to a lesser extent. ARF6-
stimulated endocytosis is inhibited by a dominant-nega-
tive form of dynamin, or a dominant-negative hub
fragment of clathrin heavy chain, indicating that it is 
mediated by clathrin. Correspondingly, overexpression 
of wild-type ARF6 (ARF6–WT) and mutant forms.
ARF6–Q67L is predicted to be deficient in GAP-stimu-
lated GTP hydrolysis and thereby locked in the active
GTP-bound state, while ARF6–T27N is predicted to be
defective in GTP binding and is probably in a GDP-bound
or nucleotide-free form. Overexpression of ARF6 mutants
in fibroblasts has yielded pleiotropic effects on endocyto-
sis, recycling, and cortical actin (5, 6, 16, 17). The localiza-
tion and function of ARF6 may vary considerably, de-
pending on the cell type. Here, we show that ARF6
regulates clathrin-mediated endocytosis at the AP PM of
polarized epithelial cells.
 
Materials and Methods
 
MDCK cells were grown as described (4). Recombinant adenoviruses en-
coding the wild-type (WT) and mutant ARF6, as well as the clathrin hub,
were produced as described (1). Levels of protein were regulated by the
concentration of doxycycline (DX), amount of virus, and length of time
after removal of DX. Very high levels of expression produced toxic ef-
fects. 0.1 ng/ml DX was included to partially repress ARF6 production.
Cells were incubated for 16–18 h to express recombinant proteins, except
clathrin hub, for 24–26 h. Unless stated, we used 60–70 pfu/cell for ARF6–
WT and ARF–Q67L, or 90–100 pfu/cell for ARF6–T27N. These produced
equal levels of the ARF6 proteins, as assayed by immunoblotting. For as-
 
says with 
 
125
 
I-IgA, 0.1 ng/ml DX was included. Using antibodies that spe-
cifically recognize the endogenous ARF6 (kind gift of V. Hsu, Harvard
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Abbreviations used in this paper:
 
 AP, apical; ARF6, ADP-ribosylation
factor 6; ARF6–T27N, mutant ARF6 predicted to be in the GDP-bound
form; ARF6–Q67L, mutant ARF6 predicted to be in the GTP-bound
form; ARF6–WT, wild-type ARF6; BL, basolateral; DX, doxycycline; gal,
galactosidase; pIgR, polymeric immunoglobulin receptor; PM, plasma
membrane; WT, wild-type.
 
of either mutant of ARF6 leads to an increase in the 
number of clathrin-coated pits at the apical plasma 
membrane. When ARF6–Q67L is overexpressed in
the presence of the dominant-negative dynamin, the 
ARF6–Q67L colocalizes with clathrin and with IgA 
bound to its receptor. We conclude that ARF6 is an im-
portant modulator of clathrin-mediated endocytosis at 
the apical surface of epithelial cells.
Key words: receptor-mediated endocytosis • polar-
ized Madin-Darby canine kidney cells • ADP-ribosyla-
tion factor 6 • apical • clathrin
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 cells have two plasma membranes (PM)
 
1
 
,
apical (AP) and basolateral (BL), which have dif-
ferent compositions and perform different func-
tions (13, 21). Clathrin-mediated endocytosis at the BL
PM resembles the constitutive endocytosis found at the
PM of nonpolarized cells (14). In contrast, clathrin-medi-
ated endocytosis at the AP PM occurs at about one fifth
the rate of the BL PM (14). Endocytosis at the AP PM can
be stimulated in response to several intracellular signaling
pathways (19), and this is essential for this PM to perform
its differentiated functions of interacting with the changing
external environment (13).
ADP-ribosylation factors (ARFs) are a group of small
GTPases that play a central role in membrane traffic (3).
The function of ARF6 has been studied by overexpression 
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Medical School, Boston, MA) the level of exogenous ARF6 was approxi-
mately fivefold, relative to endogenous ARF6. For immunofluorescence,
we omitted the DX to produce a ninefold overexpression relative to en-
dogenous ARF6. These conditions minimized the possibility of toxic ef-
fects and produced an adequate signal for our localization and functional
studies. Controls in all experiments included cells that were: not infected;
infected but the expression of ARF6, dynamin-I K44A, or clathrin hub
was fully repressed by 20 ng/ml DX; or infected with a control virus en-
coding 
 
b
 
-galactosidase (gal). These caused complete loss of the ARF6, dy-
namin-I, or hub-specific signal in immunofluorescence and biochemical
studies. Immunofluorescence was as described (11). For colocalization of
ARF6 with IgA, cells were washed with cold medium and incubated with
300 
 
m
 
g/ml IgA for 60 min.
Processing for EM was as described (2). Cells were observed at a mag-
nification of 19,000 and every third cell was photographed and viewed at
80 kV. A total of 30 randomly selected cell profiles were photographed.
The negatives were scanned using Adobe Photoshop at a resolution of
1,000 dpi. Clathrin-coated pits were easily and reproducibly discernible. A
total of 148 images were used: control, 38 images; ARF6–WT, 33 images;
ARF6–Q67L, 39 images; and ARF6–T27N, 38 images. Two observers
counted coated pits within each coded image and gave consistent observa-
tions. The length of the apical PM was measured using a ruler on Adobe
Photoshop, and the number of each type of coated pit was divided by the
length.
Endocytosis was assayed as described previously (4). For endocytosis in
the presence of clathrin hub, IgA (300 
 
m
 
g/ml) was bound for 1 h at 4
 
8
 
C
and cells were washed over 45 min. Cells were warmed to 37
 
8
 
C for 5 min.
Cells were cooled to 4
 
8
 
C and PM-bound material was stripped with
trypsin. Trypsin was neutralized with soy bean trypsin inhibitor. Cells
were fixed for 40 min on ice and IgA was stained as described. Cells ex-
pressing clathrin hub were stained with T7 antibody (Novagen, Inc.).
 
Results and Discussion
 
We used a recombinant adenovirus incorporating the tet-
racycline transactivator system to express WT ARF6 and
its mutants. Confocal microscopy showed that ARF6–WT
is associated with the AP region of the cell, and not the BL
region. Fig. 1 A shows a vertical X-Z section taken
through the plane of a monolayer of cells expressing
ARF6–WT. ARF6 staining is in green, whereas ZO-1
staining of the tight junctions is in red. Fig. 1 B shows hori-
zontal X-Y sections taken either at the level of the AP PM
(level of solid arrowhead in Fig. 1 A) or through the basal
region of the cell (level of open arrowhead in Fig. 1 A).
Both ARF6–WT and ARF6–Q67L were localized at, or
close to, the AP PM. In contrast, ARF6–T27N gave stain-
ing in both the AP and BL regions of the cell.
The AP PM tends to bulge upward in our MDCK cells,
forming a dome-like structure. We took advantage of this
to utilize the higher X-Y confocal resolution to determine
if ARF6 was entirely at the PM, or beneath the PM. Cells
were costained with antibody to gp135, an endogenous AP
PM protein. The X-Y sections in Fig. 1 C were just above
the level of the tight junction, at the level indicated by the
arrow in Fig. 1 A. In the ARF6–WT expressing cell, this
X-Y section shows the gp135 staining of the AP PM as a
narrow ring (Fig. 1 C). The ARF6–WT in the same cell is a
broader ring. The ARF6–WT staining in the outer portion
of the ring was coincident with the gp135, indicating that
this portion of the ARF6–WT is at the PM (Fig. 1 C, ar-
 
Figure 1.
 
Localization of ARF6 in MDCK cells. A, X-Z section
of ARF6–WT: ARF6,
 
 
 
green (12CA5 antibody to HA epitope);
Z0-1,
 
 
 
red. B, X-Y sections taken at AP PM (level of solid arrow-
head in A) or BL region (level of open arrowhead in A) of cells
expressing indicated protein. ARF6–WT was also expressed in
LLCPK1 cells, indicating that the AP localization of ARF6–WT
is not unique to MDCK cells. C, X-Y sections taken below apical
PM, at level of arrow in A. 
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rowhead). The inner portion of the ARF6–WT ring is un-
derneath the gp135 staining, i.e., in the cytoplasm beneath
the AP PM (arrow). Expression of ARF6–Q67L gave a
similar pattern as ARF6–WT. ARF6–T27N gave no ring,
but rather, central staining that had little overlap with
gp135, indicating that it is mostly absent from AP PM.
To examine the effects of ARF6 on endocytosis, we
used 
 
125
 
I-IgA as an endocytic marker, which can be en-
docytosed via the polymeric immunoglobulin receptor
(pIgR) at either PM. Strikingly, overexpression of either
ARF6–Q67L or ARF6–T27N stimulated endocytosis of
 
125
 
I-IgA from the AP PM (Fig. 2 A). ARF6–Q67L and
ARF6–T27N increased endocytosis during the first minute
by 
 
z
 
3-fold or 1.5-fold, respectively. In contrast, AP en-
docytosis of IgA in cells overexpressing ARF6–WT did
not markedly differ from control cells infected with a virus
encoding 
 
b
 
-gal or uninfected cells. Overexpression of
ARF6–WT or either mutant did not significantly alter the
rate or extent of BL endocytosis, recycling back to the AP
PM, BL to AP transcytosis, or BL to BL recycling (our un-
published data). Therefore, only AP endocytosis was af-
fected by ARF6.
In Fig. 2 B, levels of ARF6–Q67L or ARF6–T27N were
manipulated by infecting cells with varying amounts of
virus. The stimulatory effect of ARF6–Q67L was sig-
nificantly greater than that of ARF6–T27N at all expres-
sion levels examined. In cells simultaneously expressing
ARF6–Q67L and ARF6–T27N (achieved by double infec-
tion), we observed increased stimulation of endocytosis
above levels induced by ARF6–Q67L alone (Fig. 2 C).
We next tested if ARF6 could stimulate endocytosis of
markers that are not internalized via clathrin-coated pits.
Mutation of both cytoplasmic Tyr in pIgR gave a pIgR
that is endocytosed at about five percent of the rate of the
WT (15). Fig. 2 D shows that neither ARF6–Q67L nor
ARF6–T27N stimulated endocytosis of this mutant. ARF6
did not affect AP internalization of ricin or fluid phase
markers (our unpublished data), confirming that ARF6
does not affect nonclathrin endocytosis.
 
Figure 2.
 
Effect of ARF6 on AP endocytosis. A, Effect on rate
of endocytosis. B, Effects of varying expression level of ARF6
mutants on AP endocytosis. Cells were infected with the indi-
cated quantity of virus. Endocytosis was assayed for 5 min at
37
 
8
 
C, 1 
 
m
 
l of virus 
 
z
 
25 pfu/cell. C, Effect of coexpression of
ARF6 mutants. Cells were either infected with virus for ARF6–
Q67L plus virus for 
 
b
 
-gal (to keep the total virus constant),
ARF6–T27N plus 
 
b
 
-gal virus, or doubly infected with viruses en-
coding both ARF6 mutants. To improve temporal resolution, this
experiment was conducted at 32
 
8
 
C. D, Effect of ARF6 on en-
docytosis of endocytosis-deficient mutant pIgR. Endocytosis of
pIgR with both cytoplasmic Tyr mutated to Ala was assayed in
control cells or cells expressing ARF6–WT or mutants. In this ex-
periment only, normal MDCK cells stably expressing the pIgR-
664A, 734A, or wild-type pIgR were coinfected with the virus for
 
b
 
-gal or ARF6 mutant, plus 70–80 pfu/cell of adenovirus encod-
ing the transactivator. The level of expression of the ARF6 mu-
tant proteins was comparable to other experiments. E, Cells were
doubly infected with ARF6–Q67L and the indicated quantity of
virus for dynamin-I K44A. Endocytosis over 5 min was mea-
sured. Expression of dynamin did not alter expression of the
ARF6, as assayed by immunoblot (not shown). 
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To test if ARF6–Q67L stimulates clathrin-mediated en-
docytosis, we inhibited clathrin function by cytosol acidifi-
cation or hypertonic media, and found that ARF6–Q67L-
stimulated endocytosis was blocked (our unpublished
results). We next tested the ability of the K44A mutant of
tge dynamin-I mutant to inhibit ARF6–Q67L-stimulated
endocytosis (1). Coinfection with virus encoding dynamin-I
K44A inhibited the endocytosis stimulated by ARF6–
Q67L, and this inhibition exhibited a dependence on the
amount of dynamin-I K44A expressed (Fig. 2 E). There-
fore, endocytosis stimulated by ARF6–Q67L is dynamin-
dependent.
Overexpression of a fragment of clathrin heavy chain,
clathrin hub, acts as a dominant-negative inhibitor of
clathrin-mediated endocytosis (10). We made recombi-
nant virus expressing the hub, and coexpressing both the
Figure  3. Clathrin hub inhibits ARF6 stimulated AP endocyto-
sis. Cells were infected with 150 pfu/cell of virus expressing the
dominant-negative clathrin hub alone, or also with virus for
ARF6–WT or mutants. Cells were incubated with IgA at the AP
PM for 60 min at 48C, then at 378C for 5 min. IgA remaining on
the PM was stripped with trypsin at 48C, under conditions that re-
move .99% of PM-bound IgA. After fixation and permeabiliza-
tion, IgA was stained with antibodies to human IgA, while the
clathrin hub was stained with an antibody to its T7 epitope tag.
Arrowheads indicate cells expressing a high level of hub, which
do not endocytose IgA. Arrows indicate cells in which clathrin
hub was not detected; these cells do endocytose IgA. All cells ex-
pressed pIgR on their AP PM.
 
Figure 4.
 
ARF6 recruits clathrin to the AP PM. A, Cells were
either uninfected or infected with adenovirus for ARF6–WT or
mutants, then stained for clathrin. Confocal sections are at the
level of the arrowhead in Fig. 1 A. B, Examples of shallow and in-
vaginated clathrin-coated pits, as seen by EM. C, Total coated
pits/
 
m
 
m AP PM. D, Shallow coated pits. E, Invaginated coated
pits. 
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clathrin hub and ARF6 (WT or mutants). Uptake of IgA
was analyzed by immunofluorescence microscopy, using
the T7 epitope tag on clathrin hub to detect transfected
cells. We found an inverse correlation between expression
of clathrin hub and internalization of IgA (Fig. 3). The in-
hibition of AP IgA endocytosis by the clathrin hub was
true for cells not overexpressing ARF6, as well as cells ex-
pressing ARF6–WT and the two mutants (Fig. 3). There-
fore, AP endocytosis of IgA promoted by ARF6 mutants
is clathrin-mediated.
As ARF6-stimulated endocytosis is clathrin-mediated,
we asked if ARF6 overexpression recruited clathrin to the
AP PM. Confocal sections were taken at the level indi-
cated by the solid arrowhead in Fig. 1 A. Cells expressing
ARF6–WT have a small increase in AP PM clathrin (Fig. 4
A). Overexpression of either ARF6–Q67L or ARF6–
T27N gave a greater increase in clathrin.
We next asked if the number or morphology of clathrin-
coated pits was altered, using thin-section EM under con-
ditions where clathrin coats were easily identified. We
classified clathrin-coated pit profiles as shallow (width of
pit 
 
. 
 
depth), or invaginated (depth 
 
$ 
 
width). Examples
are shown in Fig. 4 B. Fig. 4 C shows that overexpression
of ARF6–WT gave a modest increase in coated pits, as
compared with control. This is in agreement with the small
increase in clathrin recruitment seen in Fig. 4 A. Consis-
tent with this, we found that overexpression of ARF6–WT
at a higher level than we routinely used stimulated AP en-
docytosis somewhat (data not shown). Overexpression of
either ARF6–Q67L or ARF6–T27N gave a much greater
increase of coated pit profiles. Notably, the greatest num-
ber of shallow pits was found with ARF6–T27N (Fig. 4 D;
this finding may have particular significance). In contrast,
ARF6–Q67L and ARF6–T27N gave nearly equal numbers
of invaginated pits (Fig. 4 E). These results further support
the hypothesis that ARF6 affects clathrin-mediated en-
docytosis at the AP PM.
We next investigated if ARF6 is present, even tran-
siently, in coated pits by trapping ARF6 in the deeply in-
vaginated coated pits induced by dynamin-I K44A (9). As
shown in Fig. 5, there was significant colocalization of
ARF6–WT and ARF6–Q67L with endogenous clathrin at
the AP PM of cells expressing dynamin-I K44A. This indi-
cates that ARF6 may normally cycle through coated pits,
and when coated pit pinching-off is prevented, a signifi-
cant fraction of the ARF6–WT or ARF6–Q67L can be
trapped.
We also investigated if IgA bound to pIgR at the AP
PM would accumulate in clathrin-coated pits under these
conditions. Ordinarily, although endocytic receptors such
as pIgR and TfR are concentrated 5–10-fold in clathrin-
coated pits, 
 
z
 
80–90% of these receptors are at steady
state located outside of coated pits. Fig. 5 shows that
ARF6–WT and ARF6–Q67L significantly colocalize with
IgA under these conditions.
How does ARF6 influence AP endocytosis? Like other
small GTPases, ARF6 probably has multiple effectors,
and these might be responsible for the cell type-specific
differences in ARF6 function (12). ARF6 also acts on the
cortical actin cytoskeleton (18, 20). The actin cytoskeleton
underlying the AP PM of epithelial cells has a unique or-
ganization, involving actin cores in microvilli and an un-
derlying terminal web. Cytochalasin D inhibits clathrin-
mediated endocytosis at the AP PM of MDCK cells (8).
ARF6 may act on the AP actin cytoskeleton to regulate
clathrin-mediated AP endocytosis.
Both ARF6–Q67L and ARF6–T27N stimulate AP en-
docytosis, and coexpression of the two proteins produces
an even greater stimulation. In macrophages, both ARF6–
Q67L and ARF6–T27N inhibit phagocytosis, providing a
precedent for both mutant forms of ARF6, giving effects
in the same direction (23). Although both ARF6–Q67L
and ARF6–T27N stimulate endocytosis, there are quanti-
tative and qualitative differences in their effects, suggest-
ing differences in their modes of action. ARF6–Q67L is
Figure 5. Colocalization of ARF6, clathrin, and IgA in cells ex-
pressing dynamin-I K44A. Left, Cells were infected with viruses
for dynamin-I K44A (100 pfu/cell), and either ARF6–WT or
ARF6–Q67L. Cells were treated for 5 min at 48C with 120 mg/ml
digitonin (10) to extract cytoplasmic clathrin, washed three times
with cold PBS, fixed, and processed for immunofluorescence to
detect ARF6 and endogenous clathrin. Right, Cells were infected
with viruses for pIgR, dynamin-I K44A, and either b-gal, ARF6–
WT, or ARF6–Q67L. IgA was bound to the AP PM for 1 h at
48C. Cells were warmed to 158C for 10 min. Unpermeabilized
cells were stained for IgA, then cells were extracted with digito-
nin, fixed, permeabilized, and ARF6 stained. 
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more potent in stimulating endocytosis. Although both
ARF6–Q67L and ARF6–T27N give equal increases in the
number of clathrin-coated pits, ARF6–T27N gives a
greater increase in shallow pits (Fig 4). This suggests that
ARF6–T27N may preferentially increase the formation of
shallow pits and/or decrease the rate of progression to in-
vaginated pits. In contrast, the greater increase in endocy-
tosis produced by ARF6–Q67L suggests that it acts on a
later step in endocytosis. ARF6–WT and ARF6–Q67L can
be trapped in clathrin-coated pits when pinching-off of the
pits is prevented. ARF6 may normally cycle through
coated pits, but then leaves the pits so rapidly that an accu-
mulation in coated pits is not ordinarily detectable. The
large stimulation of endocytosis caused by ARF6–Q67L
could be due to a direct action on coated pits themselves.
In contrast, ARF6–T27N is largely not on the AP PM. Its
modest stimulation of AP endocytosis may be due to an
indirect effect, e.g., via the actin cytoskeleton. Further
work will be needed to distinguish this model from other
possibilities.
Our results illustrate the importance of comparing the
localization and function of proteins in nonpolarized and
polarized cells. ARF6 may regulate a specialized endocytic
pathway in nonpolarized cells that is cognate to AP en-
docytosis in epithelial cells (7, 17, 22). As cells develop a
polarized AP PM, ARF6 and the specialized endocytic
pathway may become restricted to that PM.
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